THE CAFÉ study was published in the American Journal of Psychiatry in July 2007, and was funded by AstraZeneca. Its stated purpose was to compare AstraZeneca’s drug Seroquel (quetiapine) with other neuroleptic products. I have discussed the CAFÉ study here. Two of CAFÉ’s participants committed suicide during the study period. Both had been randomly assigned… Continue Reading
A Psychiatric Case Study. A Sad Story
One of the criticisms that I routinely make of psychiatry is that its primary agenda during initial evaluations is the assignment of a “diagnosis,” and that ongoing “treatment” consists of 15-minute “med checks,” during which drug regimens are changed and adjusted. The essence of my criticism is that this kind of approach inevitably oversimplifies human… Continue Reading
The New Holy Grail: Dysfunctional Neural Circuits
There’s a new article on Psychiatric News titled Change, Challenge, and Opportunity: Psychiatry Through the Looking Glass of Research. It’s dated October 17, and was authored by Steven Hyman, MD, and Jeffrey Lieberman, MD. Thanks to Mental Health Law on Twitter for the link. Dr. Lieberman is President of the APA. Dr. Hyman was Director… Continue Reading
Ongoing Debate with Steven Novella, MD
A few days ago I came across some text on Dr. Novella’s website that appeared to be his response to my recent critique. I drafted a response to this and posted it at 5:40 this morning. Dr. Novella has commented on this and has informed me that the material in question was not written by him…. Continue Reading
- « Previous Page
- 1
- …
- 68
- 69
- 70
- 71
- 72
- …
- 146
- Next Page »